PII-LBA5 EVIDENCE OF SUPERIOR QUALITY OF LIFE AFTER ROBOTIC PROSTATECTOMY: RESULTS FROM A POPULATION-BASED ANALYSIS
Brock O’Neil(Vanderbilt University), David F. Penson(Geriatric Research Education and Clinical Center), Richard M. Hoffman(University of Iowa), Albertsen Peter(Farmington Community Library), Tatsuki Koyama(Vanderbilt University Medical Center), Sherrie H. Kaplan(University of California, Irvine), Daniel A. Barocas(Vanderbilt University Medical Center), Sheldon Greenfield(University of California, Irvine), Xiao‐Cheng Wu(London School of Hygiene & Tropical Medicine), JoAnn Rudd(Nashville Oncology Associates), Ann S. Hamilton(University of Southern California), Cooperberg Matthew(Siemens (Canada)), Karen E. Hoffman(The University of Texas MD Anderson Cancer Center), Janet L. Stanford(Fred Hutch Cancer Center), Michael Goodman(Emory University), Matthew J. Resnick(Vanderbilt University Medical Center), Antionette Stroup(Brunswick (United States))
Cited by 0
Related Papers
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688
Prostate Cancer, Version 1.2016
|Journal of the National Comprehensive Cancer Network|2016|656